EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation

Feng Liao, Peng Liu, Liumei Wu, Tingjing Zhong, Jiaxiao Li, Jiafan Chen, Chen Wu, Ya Liu, Junzhe Chen, Geng Li, Wenbiao Wang

Molecular Therapy · 2026-08 · 34 (8) · 4903-4920

DOI: 10.1016/j.ymthe.2026.04.062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-08. Verfasst von Feng Liao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Department of Nephrology, Guangdong Provincial People's Hospital (…. Hauptthemen laut MEDLINE: Receptor, Transforming Growth Factor-beta Type II, Pulmonary Fibrosis, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Municipal Science and Technology Bureau, Department of Science and Technology of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Transforming Growth Factor-beta Type IIPulmonary FibrosisKidney DiseasesAnimalsMiceSignal TransductionDisease Models, AnimalSmad3 ProteinHumansFibrosisProteolysisTransforming Growth Factor betaKidneyBleomycinMale

Stichwörter der Autor:innen

TGF-β receptor Ⅱherbacetinpulmonary fibrosisrenal fibrosistransforming growth factor β

Substanzen

Receptor, Transforming Growth Factor-beta Type IISmad3 ProteinTransforming Growth Factor betaBleomycin

Autor:innen und Institutionen

  • Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, G…
  • Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Chinese Medicine Guangdong Laboratory, Hengqin, Guangdong 519031, China.
  • Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
  • Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China. Electronic address: chenjunzhe0304@163.com.

Förderung

  • Guangzhou Municipal Science and Technology Bureau
  • Department of Science and Technology of Guangdong Province
  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province

Zitieren

APA

Liao, F., Liu, P., Wu, L., Zhong, T., Li, J., Chen, J., Wu, C., Liu, Y., Chen, J., Li, G., & Wang, W. (2026). Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation. Molecular Therapy, 34(8), 4903-4920. https://doi.org/10.1016/j.ymthe.2026.04.062

Vancouver

Liao F, Liu P, Wu L, Zhong T, Li J, Chen J, et al. Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation. Molecular Therapy. 2026;34(8):4903-4920. doi:10.1016/j.ymthe.2026.04.062

BibTeX
@article{Liao2026,
  author = {Liao, Feng and Liu, Peng and Wu, Liumei and Zhong, Tingjing and Li, Jiaxiao and Chen, Jiafan and Wu, Chen and Liu, Ya and Chen, Junzhe and Li, Geng and Wang, Wenbiao},
  title = {Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {8},
  pages = {4903--4920},
  doi = {10.1016/j.ymthe.2026.04.062}
}
Kostenlos starten →